We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EMSN:SIXEMS-CHEMIE HOLDING AG Analysis

Data as of 2026-03-11 - not real-time

CHF 611.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

EMS‑Chemie is trading in a narrow range just above its 20‑day moving average, with the 20‑day SMA comfortably above the 50‑day SMA, signalling a modest bullish bias. Revenue has slipped year‑over‑year while operating margins remain healthy, and the latest earnings release highlighted a margin‑driven profit increase but warned of further sales pressure from currency effects. The stock offers a dividend yield above two percent, yet the payout ratio approaches seventy percent and the company reports zero operating cash flow, raising questions about dividend sustainability. Valuation multiples such as price‑to‑earnings and price‑to‑book sit at the higher end of the sector spectrum, suggesting the market has priced in growth expectations that may be optimistic given the revenue decline. Technical indicators are mixed: the RSI sits near the midpoint, the MACD histogram is negative and the signal line is bearish, while volume trends are increasing, adding a layer of short‑term uncertainty. Overall, the picture is one of a fundamentally solid specialty‑chemicals player with attractive yield but constrained by cash generation and a challenging top‑line outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish SMA crossover supports limited upside
  • Bearish MACD and mixed momentum increase downside risk
  • Increasing volume suggests active trading but no clear breakout

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong operating margins offset revenue contraction
  • Dividend yield attractive but cash flow constraints linger
  • Currency headwinds could depress future sales

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Specialty‑chemical market fundamentals remain resilient
  • Potential for margin‑driven earnings improvement
  • Dividend provides income while the company works to restore cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth-7.30%
Profit Margin23.95%
P/E Ratio30.6
P/B Ratio6.9

Technical Analysis

TrendBullish
RSI44.5
SupportCHF 600.00
ResistanceCHF 646.00
MA 20CHF 626.80
MA 50CHF 608.48
MA 200CHF 594.14
MACDBearish
VolumeIncreasing
Fear & Greed Index76.09

Valuation

Target PriceCHF 625.71
Upside/Downside2.32%
GradeOvervalued
TypeValue
Dividend Yield2.25%

Risk Assessment

Beta0.11
Volatility19.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.